Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
PayPal
PYPL
|
+$650M |
| 2 |
Home Depot
HD
|
+$617M |
| 3 |
Costco
COST
|
+$570M |
| 4 |
Caterpillar
CAT
|
+$524M |
| 5 |
AbbVie
ABBV
|
+$506M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$757M |
| 2 |
Booking.com
BKNG
|
+$555M |
| 3 |
CELG
Celgene Corp
CELG
|
+$537M |
| 4 |
Crown Castle
CCI
|
+$509M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$423M |
Sector Composition
| 1 | Technology | 20.86% |
| 2 | Consumer Discretionary | 15.65% |
| 3 | Financials | 12.8% |
| 4 | Healthcare | 12.57% |
| 5 | Communication Services | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRHC
451
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $11.6M | 0.01% |
412,387
+13,932
| +3% | +$391K |
|
452
Cintas
CTAS
$81.2B
| $11.5M | 0.01% |
+295,248
| New | +$11.5M |
|
|
CIM
453
Chimera Investment
CIM
$1.18B
| $11.2M | 0.01% |
201,432
+108
| +0.1% | +$5.99K |
|
454
Starbucks
SBUX
$94.3B
| $11.2M | 0.01% |
194,370
-200,564
| -51% | -$11.5M |
|
455
Commault Systems
CVLT
$7.87B
| $11.1M | 0.01% |
211,949
+18,574
| +10% | +$975K |
|
456
Savara
SVRA
$671M
| $10.6M | 0.01% |
+715,670
| New | +$10.6M |
|
457
Glaukos
GKOS
$5.02B
| $10.6M | 0.01% |
+412,919
| New | +$10.6M |
|
|
NSU
458
DELISTED
Nevsun Resources Ltd.
NSU
| $10.5M | 0.01% |
4,314,675
-312,952
| -7% | -$761K |
|
|
NUVA
459
DELISTED
NuVasive, Inc.
NUVA
| $10.3M | 0.01% |
175,978
-3,801
| -2% | -$222K |
|
460
CNX Resources
CNX
$4.13B
| $9.78M | 0.01% |
668,785
-462,124
| -41% | -$6.76M |
|
461
NCS Multistage Holdings
NCSM
$127M
| $9.77M | 0.01% |
33,141
+8,054
| +32% | +$2.37M |
|
462
Huron Consulting
HURN
$2.36B
| $9.74M | 0.01% |
+240,761
| New | +$9.74M |
|
|
SRUNU
463
DELISTED
Silver Run Acquisition Corporation II Units
SRUNU
| $9.68M | 0.01% |
927,116
-15,209
| -2% | -$159K |
|
464
Clearway Energy Class A
CWEN.A
$3.17B
| $9.55M | 0.01% |
506,606
+271
| +0.1% | +$5.11K |
|
465
Agios Pharmaceuticals
AGIO
$2.06B
| $9.51M | 0.01% |
166,255
+190
| +0.1% | +$10.9K |
|
466
Azenta
AZTA
$1.35B
| $9.35M | 0.01% |
392,147
+319,747
| +442% | +$7.63M |
|
467
Kinross Gold
KGC
$28B
| $9.29M | 0.01% |
+2,149,919
| New | +$9.29M |
|
468
WSFS Financial
WSFS
$3.15B
| $9.18M | 0.01% |
191,776
-1,829
| -0.9% | -$87.5K |
|
|
MRTX
469
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.9M | 0.01% |
+487,599
| New | +$8.9M |
|
470
Ocular Therapeutix
OCUL
$2.26B
| $8.88M | 0.01% |
1,994,768
+20,132
| +1% | +$89.6K |
|
471
ProQR Therapeutics
PRQR
$235M
| $8.5M | 0.01% |
2,635,552
+178,192
| +7% | +$575K |
|
|
EIGR
472
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $8.43M | 0.01% |
+20,143
| New | +$8.43M |
|
|
ICD
473
DELISTED
Independence Contract Drilling, Inc.
ICD
| $8.28M | 0.01% |
104,029
-203
| -0.2% | -$16.2K |
|
|
WFT
474
DELISTED
Weatherford International plc
WFT
| $8.14M | 0.01% |
1,951,463
-72,845
| -4% | -$304K |
|
475
Select Water Solutions
WTTR
$932M
| $7.79M | 0.01% |
427,099
-520
| -0.1% | -$9.48K |
|